Perachino, M. and Eandi, M. 2013. The utility of a model-based cost-effectiveness analysis of degarelix versus leuprolide in the therapy of hormone-dependent advanced prostate cancer. Farmeconomia. Health economics and therapeutic pathways. 14, 3 (Sep. 2013), 131–146. DOI:https://doi.org/10.7175/fe.v14i3.700.